1,458
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Lymphoma-like double-hit genetic abnormalities (MYC/IGH and IGH/BCL2) in a case of non-secretory multiple myeloma

, ORCID Icon, , , ORCID Icon & ORCID Icon
Pages 243-246 | Received 11 Aug 2020, Accepted 03 Sep 2020, Published online: 21 Sep 2020

References

  • Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC; 2017.
  • Snuderl M, Kolman OK, Chen, YB, et al. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. Am J Surg Pathol. 2010;34(3):327–340.
  • Tomita N, Tokunaka M, Nakamura N, et al. Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations. Haematologica. 2009;94(7) :935–943.
  • Miao Y, Hu S, Lu X, et al. Double-hit follicular lymphoma with MYC and BCL2 translocations: a study of 7 cases with a review of literature. Hum Pathol. 2016;58:72–77.
  • Miyaoka M, Kikuti YY, Carreras J, et al. Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements. Mod Pathol. 2018;31(2):313–326.
  • Ziemba JB, Wolf Z, Weinstock M, et al. Double-hit and triple-hit follicular lymphoma. Am J Clin Pathol. 2020.
  • Avet-Loiseau H, Gerson F, Magrangeas F, Intergroupe Francophone du Myélome, et al. Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors. Blood. 2001;98(10):3082–3086.
  • Bergsagel PL, Kuehl WM. Chromosome translocations in multiple myeloma. Oncogene. 2001; 20(40):5611–5622.
  • Misund K, Keane N, Stein CK, MMRF CoMMpass Network, et al. MYC dysregulation in the progression of multiple myeloma. Leukemia. 2020;34(1):322–326.
  • Shou Y, Martelli ML, Gabrea A, et al. Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma. Proc Natl Acad Sci Usa. 2000;97(1):228–233.
  • Gong J-N, Khong T, Segal D, et al. Hierarchy for targeting prosurvival BCL2 family proteins in multiple myeloma: pivotal role of MCL1. Blood. 2016;128(14):1834–1844.
  • Kalff A, Khong T, Wall M, et al. A rare case of IGH/MYC and IGH/BCL2 double hit primary plasma cell leukemia. Haematologica. 2015;100(2):e60–e62.
  • Nishida K, Tamura A, Nakazawa N, et al. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization. Blood. 1997;90(2):526–534.